Moist Wound Dressings Market - By Product (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings), By Application (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical & Traumatic Wounds, Burns), By End-use – Global Forecast, 2023-2032

Moist Wound Dressings Market - By Product (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings), By Application (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical & Traumatic Wounds, Burns), By End-use – Global Forecast, 2023-2032

Moist Wound Dressings Market Size

Moist Wound Dressings Market was valued at USD 4.3 billion in 2022 and is estimated to account for USD 7.2 billion by 2032. Moist wound dressings, also known as advanced wound dressings or moist wound care, are specialized dressings used in the management and treatment of various types of wounds. These dressings maintain a moist environment around the wound, which has been found to promote better wound healing compared to traditional dry dressings.
 

Further, advance wound care dressings create a moist and humid environment around the wound. This is beneficial because it supports several aspects of the wound healing process. The increasing incidence of burn injuries is one of the major factors driving the demand for moist wound dressings. Several factors contribute to the rising incidence of burn injuries, including accidents at home, workplace incidents, electrical mishaps, and natural disasters. For instance, according to the World Health Organization (WHO), an estimated 180,000 deaths occur annually due to burns, with the majority of these deaths occurring in low- and middle-income countries. Additionally, the American Burn Association reports that in the U.S., there are approximately 486,000 burn injuries treated annually, and about 40,000 of these require hospitalization.
 

Furthermore, the growing prevalence of diabetes worldwide is a significant factor contributing to delayed wound healing. Diabetes can lead to various complications, including impaired blood circulation, neuropathy (nerve damage), and weakened immune function, all of which can hinder the body's ability to heal wounds efficiently. For instance, in 2021, according to the International Diabetes Federation (IDF), about 463 million adults (aged 20-79) had diabetes worldwide. This number is projected to rise to 700 million by 2045 in case of continuing present trends.

Moreover, about 15-25% of people with diabetes will develop a foot ulcer at some point in their lives, and these ulcers can be challenging to heal. Diabetic foot ulcers are a common complication and are a major cause of hospital admissions in people with diabetes. Thus, this growing prevalence of diabetes is anticipated to boost demand of moist wound dressings and thereby further accelerate market trends.
 

COVID-19 Impact

The emergence of the COVID-19 pandemic significantly accelerated the moist wound dressings market. During the pandemic, there was heightened awareness of infection control and prevention. Healthcare facilities and caregivers paid increased attention to wound care to prevent infections in patients, including those with COVID-19 thereby this led to high demand of wound care biologics, negative pressure wound therapy, rapid self-healing gel, moist wound dressings, among others. Moist wound dressings, with their ability to create a barrier against pathogens, became even more crucial in wound management.
 

Moreover, the pandemic led to a shift in the way healthcare services were delivered, with more emphasis on home healthcare and telemedicine to reduce the burden on hospitals. This change increased the demand for wound care products that could be used in non-hospital settings, including moist wound dressings suitable for home care.
 

Moist Wound Dressings Market Trends

The increasing prevalence of acute and chronic wounds is a significant concern in healthcare, with implications for the market. These wounds can result from various causes, including accidents, surgeries, chronic health conditions, and lifestyle factors. Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are particularly common. In the U.S., for instance, it is estimated that there are over 6 million chronic wound cases annually.
 

Furthermore, diabetes-related foot ulcers are a prime example of chronic wounds. These ulcers can develop due to neuropathy and reduced blood flow, and often require specialized wound care, including the use of moist wound dressings. Additionally, growing government initiatives towards trauma cases, developing healthcare infrastructure, and patient support programs will spur the adoption of moist wound dressings, and thus propelling market revenue growth.
 

Moist Wound Dressings Market Analysis

The moist wound dressings market by product is categorized into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings and others. The foam dressings segment garnered USD 1 billion revenue size in the year 2022. The dominance of the segment can be attributed to its versatility and effectiveness in wound care. Furthermore, foam dressings are highly absorbent and can effectively manage wound exudate (fluid that oozes from a wound). They help maintain a moist wound environment while preventing excessive moisture buildup, which can be detrimental to wound healing.
 

Additionally, foam dressings are soft, pliable, and cushioned, providing comfort to the patient. Their gentle adherence to the skin minimizes trauma during dressing changes, reducing pain and discomfort for the patient.
 

Based on application, the moist wound dressings market is segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, surgical & traumatic wounds, burns, and others. The diabetic foot ulcers segment accounted for 28.1% business share in the year 2022 and is anticipated to witness the highest growth during the forecast period. Diabetic foot ulcers are commonly treated using moist wound dressings because they benefit from a moist wound healing environment. These ulcers, which often occur in individuals with diabetes, can be slow to heal and prone to complications due to the underlying factors associated with diabetes.
 

Additionally, moist wound dressings maintain a controlled moisture level at the wound site, which is conducive to the natural wound healing process. They provide an ideal environment for cellular proliferation, tissue regeneration, and the formation of new blood vessels (angiogenesis). Further, diabetic patients are at an increased risk of wound infections due to compromised immune function and poor circulation. Moist dressings help create a barrier against external contaminants, reducing the risk of infection, thereby promoting segment trends.
 

The moist wound dressings market by end-use is categorized into hospitals, clinics, and others. The hospital segment garnered USD 1.9 billion revenue size in 2022. Performing wound dressings in hospitals offers several advantages, as hospitals are equipped with specialized resources and healthcare professionals trained to provide comprehensive wound care. Hospitals have wound care teams and specialized wound care nurses that are experienced in assessing, treating, and managing various types of wounds. They are well informed about the latest wound care techniques and technologies.
 

Further, hospitals typically have a wide range of advanced wound care products, including specialized dressings, negative pressure wound therapy devices, and other innovative wound management tools. This ensures that the most appropriate and effective dressing can be selected for each patient's unique wound.
 

The U.S. moist wound dressings market accounted for USD 1.6 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. Increasing geriatric population base along with the rising incidence of diabetes in the country will drive the U.S. market size. Moreover, increasing government initiatives towards diabetes care will further accelerate industry expansion.
 

For instance, National Diabetes Education Program (NDEP) is the joint effort of the National Institutes of Health and Centers for Disease Control and Prevention (CDC). National Diabetes Education Program seeks at reducing burden of prediabetes by delivering diabetes-related education to a range of people of emerging nations, faith-based organizations, ethnic minorities, community-based organizations, and healthcare providers. Furthermore, the strong focus on research and development and continuous innovation in moist wound dressings will bolster the market demand.
 

Moist Wound Dressings Market Share

Some of the eminent market participants operating in the moist wound dressings market include

• Coloplast A/S
• Medline Industries, Inc.
• Smith & Nephew
• Convatech Inc.
• Systagenix
• Derma Science, Inc.
• Cardinal Health
• Acelity
• 3M
• B.Braun Medical Inc.

Braun Medical Inc, among others. These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
 

Moist Wound Dressings Industry News

• In July 2023, JeNaCell (an Evonik company), announced the launch of a moist wound dressing called epicite balance for treatment of chronic wounds. Biosynthetic cellulose, a hydropolymer for cutting-edge medical device applications, is used to make epicite balance. The dressing speeds up delayed wound healing and provides great wound cleansing properties. This product launch enhanced the customer base along with the geographical presence of the firm.
   
• In October 2022, Healthium Medtech introduced a new wound dressing product portfolio called Theruptor Novo for the treatment and management of chronic wounds including legs ulcers and diabetic foot ulcers. The launch of Theruptor Novo broadened the company’s product portfolio in the field of advanced wound dressing.
   

Moist wound dressings market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product (USD Million and Units)

• Foam dressings
• Hydrocolloid dressings
• Film dressings
• Alginate dressings
• Hydrogel dressings
• Others

By Application (USD Million)

• Diabetic foot ulcers
• Pressure ulcers
• Venous leg ulcers
• Surgical & traumatic wounds
• Burns
• Others

By End-use (USD Million)

• Hospitals
• Clinics
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey